Technology
Health
Medical

Apellis Pharmaceuticals

461

$27.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.21 (+8.66%) Today
$0.00 (0.00%) As of 4:01 AM EDT after-hours

Why Robinhood?

You can buy or sell APLS and other stocks, options, ETFs, and crypto commission-free!

About APLS

Apellis Pharmaceuticals, Inc. Common Stock, also called Apellis Pharmaceuticals, is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. Read More It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

CEO
Cedric Francois, MD, PhD
Employees
235
Headquarters
Waltham, Massachusetts
Founded
2009
Market Cap
1.77B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
871.35K
High Today
$27.81
Low Today
$25.40
Open Price
$25.75
Volume
940.39K
52 Week High
$45.04
52 Week Low
$16.85

Collections

Technology
Health
Medical
Biopharmaceutical
Pharmaceutical
2017 IPO
US
North America

APLS Earnings

-$1.77
-$1.18
-$0.59
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6

People Also Bought

Amarin

33,844

$5.80

+15.08%

Amarin

33,844

$5.80

+15.08%

Viking Therapeutics

53,256

$4.93

+7.88%

Myovant Sciences

5,182

$8.75

+11.61%

Aurinia Pharmaceuticals

11,200

$14.84

+2.34%

You May Also Like

CHMI
JNUG
XES
NRC
TBT
KHC
TTTN
JPM-H
CBRL
UDR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy APLS

Market Price$27.72
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell APLS stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up